[Abzug MJ, Cloud G, Bradley J, Sanchez PJ, Romero J, Powell D, et al. Double blind placebo-controlled trial of pleconaril in inmfants with enterovirus meningitis. Pediatr Infect Dis. 2003; 36: 1523-1532.]Search in Google Scholar
[Aitken C, Jeffries DJ Nosocomial spread of viral disease. Clinical Microbiology Review. 2001; 14: 528-546.10.1128/CMR.14.3.528-546.2001]Search in Google Scholar
[Archard LC, Richardson PJ, Olsen EG, Dubowitz V, Sewry C, Bowles NE. The role of coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease. Biochem Soc Symp. 1987; 53: 51-62.]Search in Google Scholar
[Aradottir E., Alonso EM, Shulman ST. Severe neonatal enteroviral hepatitis treated with plrconaril. Pediatr Infect Dis. 2001; 20: 457-459.10.1097/00006454-200104000-00022]Search in Google Scholar
[Chuang JH. (Enterovirus surveillance may be insufficient for estimating burden in Taiwan. Presented at: 14th International Congress on Infectious Diseases, March 9-12th, 2010; Miami, USA. Poster #40.005. 2010.]Search in Google Scholar
[Diana GD, Rudewicz P., Pevear DC, Nitz TJ, Aldous SC, Robinson DT, et al. Picornavirus inhibitors: Trifluromethyl substitution provides a global protective effect against hepatic metabolism. J Med Chem. 1995; 38: 1355-1371.10.1021/jm00008a014]Search in Google Scholar
[Galabov AS, Angelova A. Antiviral agents in the prevention and treatment of virus-induced diabetes. Anti-Infective Agents in Medicinal Chemistry. 2006; 5: 293-307.10.2174/187152106777697826]Search in Google Scholar
[Hayden FG, Herrington DT, Coats TL, Kim K, Cooper EC, Villano SA, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: Results of 2 double-blind, randomized, placebo- controlled trials. Clin Inf Dis. 2003; 36: 1523-1532.10.1086/375069]Search in Google Scholar
[Herrmann EC Jr, Herrmann JA. A working hypothesis - virus resistance development as an indicator of specific antiviral activity. Ann NY Acad Sci. 1977; 284: 632-637.10.1111/j.1749-6632.1977.tb21997.x]Search in Google Scholar
[Herrmann EC Jr, Herrmann JA, DeLong DC. Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles. Antiviral Res. 1982; 2: 339-346.10.1016/0166-3542(82)90003-1]Search in Google Scholar
[Hyoty H, Taylor KW. The role of viruses in human diabetes. Diabetologia. 2002; 45: 1353-136110.1007/s00125-002-0852-3]Search in Google Scholar
[Loddo B. Development of drug resistance and dependence in viruses. Pharm Ther. 1980; 10: 431-46010.1016/0163-7258(80)90026-1]Search in Google Scholar
[Mallia P, Contoli M, Caramori G, Pandit A, Johnston SL, Papi A. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. Current pahrmaceutical Design. 2007; 13: 73-97.10.2174/13816120777931377717266589]Search in Google Scholar
[Melnick JL, Crowther D, Barrera-Oro J. Rapid development of drug-resistant mutants of poliovirus. Science. 1961; 134: 557-557.10.1126/science.134.3478.557]Search in Google Scholar
[Morens DM, Pallansch MA. Epidemiology. In: Rotbart HA (ed) Human Enterovirus Infections. Washington DC ASM Press. 1995.]Search in Google Scholar
[Nikolaeva L, Galabov AS. Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication. Acta virol. 1995; 39: 235-241.]Search in Google Scholar
[Nikolaeva L, Galabov AS. Cytotoxicity of the synergistic antienteroviral combination of enviroxime and disoxaril. Acta virol. 1999a; 43: 263-265.]Search in Google Scholar
[Nikolaeva L, Galabov AS. In vitro inhibitory effects of dual combinations of picornavirus replication inhibittors. Acta virol. 1999b; 43: 303-311.]Search in Google Scholar
[Nikolaeva L, Galabov AS. Antiviral effect of the combination of enviroxim and disoxaril on Coxsackievirus B1 infection. Acta virol. 2000; 44: 73-78.]Search in Google Scholar
[Nikolaeva-Glomb L, Galabov AS. Synergistic drug combinations against the in vitro replication of Coxackie B1 virus. Antiviral Res. 2004; 16: 41-46.]Search in Google Scholar
[Nikolova I, Galabov AS. Development of resistance to disoxaril in coxsackie B1 virus infected newborn mice. Antivir Res. 2003; 60: 35-40.10.1016/S0166-3542(03)00150-5]Search in Google Scholar
[Pallansch M, Roos R. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Knipe DM, Howley PM (ed) Fields Virology, Fifth Edition, Philadelphia, Lippincott Williams & Wilkins. 2006; pp. 895-910.]Search in Google Scholar
[Pallansch MA. Enterovirus infections, including poliomyelitis. In: Guerrant RL, Walker DH, Weller PF (ed) Tropical Infectious Diseases. Principles, Pathogens and Practice. 3rd edn. 2011.10.1016/B978-0-7020-3935-5.00060-4]Search in Google Scholar
[Prichard MN, Shipman CJr. A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 1990; 14: 181-206.10.1016/0166-3542(90)90001-N]Search in Google Scholar
[Rotbart HA, Webster AD. Treatment of potentially lifethreatening enterovirus infections with plrconaril. Clin Infect Dis. 2001; 32: 228-235.10.1086/318452]Search in Google Scholar
[Schultheiss HP, Kuhl U. Overview on chronic viral cardiomyopathy/chronic myocarditis. Ernst Schering Res Found Workshop. 2006; 55: 3-18.10.1007/3-540-30822-9_1]Search in Google Scholar
[Senior K. FDA panel rejects common cold treatment. Lancet Infect Dis. 2002; 2: 264.10.1016/S1473-3099(02)00277-3]Search in Google Scholar
[Strauss J, Strauss E. Plus-Strand RNA Viruses. In: Viruses and Human Disease. 2008; pp 63-136.10.1016/B978-0-12-373741-0.50006-4]Search in Google Scholar
[Tan W C. Viruses in asthma exacerbations. Current Opinion in Pulmonary Medicine. 2005; 11: 21-26.]Search in Google Scholar
[Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol. 2011; 33: 45-55.10.1007/s00281-010-0207-y20424841]Search in Google Scholar
[Turner RB, Dutko FJ, Goldstein NH, Lockwood G, Hayden FG. Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob Agents Chemother. 1993; 33: 2069-2074.10.1128/AAC.37.2.2971876568383943]Search in Google Scholar
[Turner RB, Hendley O. Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother. 2005; 56: 805-807.10.1093/jac/dki32916159927]Search in Google Scholar
[Vassileva-Pencheva R, Galabov AS. Avoiding drug-resistance development by novel approach of combining enteroviral substances against coxsackievirus B1 infection in mice. Antiviral Res. 2010; 85: 366-372.10.1016/j.antiviral.2009.11.00319900482]Search in Google Scholar